HCP
Get informed when a big investor buys or sells
+ FollowOvervalued by 197.4% based on the discounted cash flow analysis.
| Market cap | $7.11 Billion |
|---|---|
| Enterprise Value | $6.52 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.98 |
| Beta | 1.19 |
| Outstanding Shares | 203,526,000 |
| P/E Ratio | -35.36 |
|---|---|
| PEG | 52.73 |
| Price to Sales | 11.59 |
| Price to Book Ratio | 5.8 |
| Enterprise Value to Revenue | 9.95 |
| Enterprise Value to EBIT | -36.49 |
| Enterprise Value to Net Income | -54 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.26 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data